SCHEMBL3044684

SCHEMBL3044684

C(#Cc1cccnc1)CCCCCCC#Cc1cccnc1

nearest known ligand 0.71

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 5/20 0.70
CHRNA4 P43681 5/20 0.70
CYP2A6 P11509 5/20 0.65
CYP2C9 P11712 3/20 0.65
CYP2B6 P20813 3/20 0.65
CYP2C19 P33261 3/20 0.65
CYP2D6 P10635 3/20 0.65
CYP2E1 P05181 2/20 0.65
CYP3A4 P08684 2/20 0.65
CYP1A2 P05177 2/20 0.62
CYP2C8 P10632 1/20 0.62
DRD2 P14416 1/20 0.47
DRD4 P21917 1/20 0.47
DRD3 P35462 1/20 0.47
GRM5 P41594 2/20 0.44
FFAR1 O14842 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10893588 0.92 CHRNB2 (0.60) CHRNB2CHRNA4CYP2A6CYP2C9CYP2B6
SCHEMBL29187190 0.92 CHRNB2 (0.65) CHRNB2CHRNA4CYP2A6CYP2C9CYP2B6
SCHEMBL3064618 0.90 CHRNB2 (0.67) CHRNB2CHRNA4CYP2A6CYP2C9CYP2B6
SCHEMBL9262058 0.90 CHRNB2 (0.62) CHRNB2CHRNA4CYP2A6CYP2C9CYP2B6
SCHEMBL13088099 0.87 CHRNB2 (0.56) CHRNB2CHRNA4CYP2A6CYP2C9CYP2B6
SCHEMBL15921874 0.87 CHRNB2 (0.64) CHRNB2CHRNA4CYP2A6CYP2C9CYP2B6
SCHEMBL3673693 0.87 CHRNB2 (0.69) CHRNB2CHRNA4CYP2A6CYP2C9CYP2B6
SCHEMBL1841748 0.87 CHRNB2 (0.64) CHRNB2CHRNA4CYP2A6CYP2C9CYP2B6
SCHEMBL10889195 0.86 CHRNB2 (0.62) CHRNB2CHRNA4CYP2A6CYP2C9CYP2B6
SCHEMBL23014727 0.85 CHRNB2 (0.57) CHRNB2CHRNA4CYP2A6CYP2C9CYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9649301-B2 Bis-quaternary ammonium cyclophane compounds that interact with neuronal nicotinic acetylcholine receptors UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2017-05-16 US disclosed
US-9649301-B2 Bis-quaternary ammonium cyclophane compounds that interact with neuronal nicotinic acetylcholine receptors UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2017-05-16 US disclosed
US-9649301-B2 Bis-quaternary ammonium cyclophane compounds that interact with neuronal nicotinic acetylcholine receptors UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2017-05-16 US disclosed
US-20150352088-A1 Bis-Quaternary Ammonium Cyclophane Compounds that Interact with Neuronal Nicotinic Acetylcholine Receptors UNIV KENTUCKY RES FOUND (US) 2015-12-10 US disclosed
US-20150352088-A1 Bis-Quaternary Ammonium Cyclophane Compounds that Interact with Neuronal Nicotinic Acetylcholine Receptors UNIV KENTUCKY RES FOUND (US) 2015-12-10 US disclosed
US-20140080859-A1 Bis-Quaternary Ammonium Cyclophane Compounds that Interact with Neuronal Nicotinic Acetylcholine Receptors UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2014-03-20 US disclosed
US-20140080859-A1 Bis-Quaternary Ammonium Cyclophane Compounds that Interact with Neuronal Nicotinic Acetylcholine Receptors UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2014-03-20 US disclosed
US-8653275-B2 Bis-quaternary ammonium cyclophane compounds that interact with neuronal nicotinic acetylcholine receptors UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2014-02-18 US disclosed
US-8653275-B2 Bis-quaternary ammonium cyclophane compounds that interact with neuronal nicotinic acetylcholine receptors UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2014-02-18 US disclosed
US-20100222377-A1 BIS-QUATERNARY AMMONIUM CYCLOPHANE COMPOUNDS THAT INTERACT WITH NEURONAL NICOTINIC ACETYLCHOLINE RECEPTORS UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2010-09-02 US disclosed
US-20100222377-A1 BIS-QUATERNARY AMMONIUM CYCLOPHANE COMPOUNDS THAT INTERACT WITH NEURONAL NICOTINIC ACETYLCHOLINE RECEPTORS UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2010-09-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140080859-A1 Bis-Quaternary Ammonium Cyclophane Compounds that Interact with Neuronal Nicotinic Acetylcholine Receptors CHRNG, CHRNA10, CHRNA4 CHRNB2 12/4885CHRNA4 3/4885CYP2A6 1405/4885
US-20100222377-A1 BIS-QUATERNARY AMMONIUM CYCLOPHANE COMPOUNDS THAT INTERACT WITH NEURONAL NICOTINIC ACETYLCHOLINE RECEPTORS CHRNG, CHRNA10, CHRNA4 CHRNB2 12/4885CHRNA4 3/4885CYP2A6 1405/4885
US-20150352088-A1 Bis-Quaternary Ammonium Cyclophane Compounds that Interact with Neuronal Nicotinic Acetylcholine Receptors CHRNG, CHRNA10, CHRNA4 CHRNB2 12/4885CHRNA4 3/4885CYP2A6 1405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.